๐๐๐ฐ๐๐จ๐ซ๐ง ๐๐๐ง๐๐ญ๐ข๐ ๐๐๐ฌ๐ญ๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ข๐ณ๐ ๐ญ๐จ ๐๐๐๐๐ก ๐๐๐ ๐.๐ ๐๐ง ๐๐ฒ ๐๐๐๐
According to the Regional Research Reports, the Global Newborn Genetic Testing market is anticipated to reach USD ** billion by 2030 from USD 4.8 billion in 2021. The global Newborn Genetic Testing market is projected to grow at a CAGR of 10.7% from 2022 to 2030. The increasing prevalence of genetic diseases among infants is the major factor positively influencing the growth of the newborn genetic testing market. The risk of genetic diseases in infants is high when parents have another child suffering from a genetic disease or if either of the parents has an abnormality in their chromosomes.
Due to the rising number of cases of genetic disorders in infants, governments of many regions are promoting the use of prenatal and newborn genetic testing. Therefore, this factor is further boosting the growth of the market.
Request To Download Sample of This Strategic Report: https://www.regionalresearchreports.com/request-sample/global-newborn-genetic-testing-market/HC-1370?utm_source=Free&utm_medium=Harsh+17+april
Global Newborn Genetic Testing Market Segmentation
Regional Research Reports has segmented the global Newborn Genetic Testing market based on diagnostic, disease, and end user at a regional and global level. Geographically, the research report has considered the five regions: North America, Europe, Asia Pacific, South America, and the Middle East & Africa. Moreover, the research study focuses on the market analysis of the tier-1 countries, such as the USA, China, Germany, India, the UK, Japan, France, Italy, Spain, Russia, South Korea, and other territories.
Global Newborn Genetic Testing Market Analysis by Diagnostic
Spectrophotometer
Polymerase Chain Reaction
Fluorescence in-situ Hybridization
Array-Comparative Genomic Hybridization
Screening
Maternal Serum Screening
Chronic Villus Sampling
Amniocentesis
Non-invasive Prenatal Testing
Global Newborn Genetic Testing Market Analysis by Disease
Cystic Fibrosis
Sickle Cell Anemia
Down Syndrome
Phenylketonuria
Others
Global Newborn Genetic Testing Market Analysis by End User
Hospitals & Clinics
Diagnostic Centers
Others
Global Newborn Genetic Testing Market Growth, by Region and Country, 2018-2021, 2022-2030 (US$ Millions)
Global Newborn Genetic Testing Market Analysis by Region and Country
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Italy, Spain, Russia, Switzerland, Poland, Belgium, the Netherlands, Norway, Sweden, Czech Republic, Slovakia, Slovenia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Indonesia, Thailand, Malaysia, Vietnam, Singapore, Australia & New Zealand, Rest of Asia Pacific)
South America (Brazil, Argentina, Peru, Colombia, Rest of South America)
The Middle East & Africa (UAE, Saudi Arabia, South Africa, Egypt, Qatar, Northern Africa, Rest of MEA)
You Can Purchase Complete Report: https://www.regionalresearchreports.com/buy-now/global-newborn-genetic-testing-market/HC-1370?opt=2950&utm_source=Free&utm_medium=Harsh+17+april
Global Newborn Genetic Testing Market Competitive: Key Players
The report includes a comprehensive analysis of leading market players, such as:
Key companies Newborn Genetic Testing revenues in the global market, 2018-2021 (Estimated), (US$ Millions)
Key companies Newborn Genetic Testing revenues market share in global market, 2021 (%)
Key companies Newborn Genetic Testing sold in the global market, 2018-2021 (Estimated)
Leading Newborn Genetic Testing Manufacturers –
Ariosa Diagnostics (Roche)
Berry Genomics
BGI
Bio-Rad Laboratories Inc.
Illumina
Laboratory Corporation of America
Natera
Qiagen
Sequenom
Trivitron Healthcare
Verinata Health
Agilent Technologies Inc.
Quest Diagnostics Incorporated
F. Hoffmann La-Roche Ltd.
PerkinElmer, Inc.
According to the Regional Research Reports, the Global Newborn Genetic Testing market is anticipated to reach USD ** billion by 2030 from USD 4.8 billion in 2021. The global Newborn Genetic Testing market is projected to grow at a CAGR of 10.7% from 2022 to 2030. The increasing prevalence of genetic diseases among infants is the major factor positively influencing the growth of the newborn genetic testing market. The risk of genetic diseases in infants is high when parents have another child suffering from a genetic disease or if either of the parents has an abnormality in their chromosomes.
Due to the rising number of cases of genetic disorders in infants, governments of many regions are promoting the use of prenatal and newborn genetic testing. Therefore, this factor is further boosting the growth of the market.
Request To Download Sample of This Strategic Report: https://www.regionalresearchreports.com/request-sample/global-newborn-genetic-testing-market/HC-1370?utm_source=Free&utm_medium=Harsh+17+april
Global Newborn Genetic Testing Market Segmentation
Regional Research Reports has segmented the global Newborn Genetic Testing market based on diagnostic, disease, and end user at a regional and global level. Geographically, the research report has considered the five regions: North America, Europe, Asia Pacific, South America, and the Middle East & Africa. Moreover, the research study focuses on the market analysis of the tier-1 countries, such as the USA, China, Germany, India, the UK, Japan, France, Italy, Spain, Russia, South Korea, and other territories.
Global Newborn Genetic Testing Market Analysis by Diagnostic
Spectrophotometer
Polymerase Chain Reaction
Fluorescence in-situ Hybridization
Array-Comparative Genomic Hybridization
Screening
Maternal Serum Screening
Chronic Villus Sampling
Amniocentesis
Non-invasive Prenatal Testing
Global Newborn Genetic Testing Market Analysis by Disease
Cystic Fibrosis
Sickle Cell Anemia
Down Syndrome
Phenylketonuria
Others
Global Newborn Genetic Testing Market Analysis by End User
Hospitals & Clinics
Diagnostic Centers
Others
Global Newborn Genetic Testing Market Growth, by Region and Country, 2018-2021, 2022-2030 (US$ Millions)
Global Newborn Genetic Testing Market Analysis by Region and Country
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Italy, Spain, Russia, Switzerland, Poland, Belgium, the Netherlands, Norway, Sweden, Czech Republic, Slovakia, Slovenia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Indonesia, Thailand, Malaysia, Vietnam, Singapore, Australia & New Zealand, Rest of Asia Pacific)
South America (Brazil, Argentina, Peru, Colombia, Rest of South America)
The Middle East & Africa (UAE, Saudi Arabia, South Africa, Egypt, Qatar, Northern Africa, Rest of MEA)
You Can Purchase Complete Report: https://www.regionalresearchreports.com/buy-now/global-newborn-genetic-testing-market/HC-1370?opt=2950&utm_source=Free&utm_medium=Harsh+17+april
Global Newborn Genetic Testing Market Competitive: Key Players
The report includes a comprehensive analysis of leading market players, such as:
Key companies Newborn Genetic Testing revenues in the global market, 2018-2021 (Estimated), (US$ Millions)
Key companies Newborn Genetic Testing revenues market share in global market, 2021 (%)
Key companies Newborn Genetic Testing sold in the global market, 2018-2021 (Estimated)
Leading Newborn Genetic Testing Manufacturers –
Ariosa Diagnostics (Roche)
Berry Genomics
BGI
Bio-Rad Laboratories Inc.
Illumina
Laboratory Corporation of America
Natera
Qiagen
Sequenom
Trivitron Healthcare
Verinata Health
Agilent Technologies Inc.
Quest Diagnostics Incorporated
F. Hoffmann La-Roche Ltd.
PerkinElmer, Inc.
๐๐๐ฐ๐๐จ๐ซ๐ง ๐๐๐ง๐๐ญ๐ข๐ ๐๐๐ฌ๐ญ๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ข๐ณ๐ ๐ญ๐จ ๐๐๐๐๐ก ๐๐๐ ๐.๐ ๐๐ง ๐๐ฒ ๐๐๐๐
According to the Regional Research Reports, the Global Newborn Genetic Testing market is anticipated to reach USD XX billion by 2030 from USD 4.8 billion in 2021. The global Newborn Genetic Testing market is projected to grow at a CAGR of 10.7% from 2022 to 2030. The increasing prevalence of genetic diseases among infants is the major factor positively influencing the growth of the newborn genetic testing market. The risk of genetic diseases in infants is high when parents have another child suffering from a genetic disease or if either of the parents has an abnormality in their chromosomes.
Due to the rising number of cases of genetic disorders in infants, governments of many regions are promoting the use of prenatal and newborn genetic testing. Therefore, this factor is further boosting the growth of the market.
Request To Download Sample of This Strategic Report: https://www.regionalresearchreports.com/request-sample/global-newborn-genetic-testing-market/HC-1370?utm_source=Free&utm_medium=Harsh+17+april
Global Newborn Genetic Testing Market Segmentation
Regional Research Reports has segmented the global Newborn Genetic Testing market based on diagnostic, disease, and end user at a regional and global level. Geographically, the research report has considered the five regions: North America, Europe, Asia Pacific, South America, and the Middle East & Africa. Moreover, the research study focuses on the market analysis of the tier-1 countries, such as the USA, China, Germany, India, the UK, Japan, France, Italy, Spain, Russia, South Korea, and other territories.
Global Newborn Genetic Testing Market Analysis by Diagnostic
Spectrophotometer
Polymerase Chain Reaction
Fluorescence in-situ Hybridization
Array-Comparative Genomic Hybridization
Screening
Maternal Serum Screening
Chronic Villus Sampling
Amniocentesis
Non-invasive Prenatal Testing
Global Newborn Genetic Testing Market Analysis by Disease
Cystic Fibrosis
Sickle Cell Anemia
Down Syndrome
Phenylketonuria
Others
Global Newborn Genetic Testing Market Analysis by End User
Hospitals & Clinics
Diagnostic Centers
Others
Global Newborn Genetic Testing Market Growth, by Region and Country, 2018-2021, 2022-2030 (US$ Millions)
Global Newborn Genetic Testing Market Analysis by Region and Country
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Italy, Spain, Russia, Switzerland, Poland, Belgium, the Netherlands, Norway, Sweden, Czech Republic, Slovakia, Slovenia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Indonesia, Thailand, Malaysia, Vietnam, Singapore, Australia & New Zealand, Rest of Asia Pacific)
South America (Brazil, Argentina, Peru, Colombia, Rest of South America)
The Middle East & Africa (UAE, Saudi Arabia, South Africa, Egypt, Qatar, Northern Africa, Rest of MEA)
You Can Purchase Complete Report: https://www.regionalresearchreports.com/buy-now/global-newborn-genetic-testing-market/HC-1370?opt=2950&utm_source=Free&utm_medium=Harsh+17+april
Global Newborn Genetic Testing Market Competitive: Key Players
The report includes a comprehensive analysis of leading market players, such as:
Key companies Newborn Genetic Testing revenues in the global market, 2018-2021 (Estimated), (US$ Millions)
Key companies Newborn Genetic Testing revenues market share in global market, 2021 (%)
Key companies Newborn Genetic Testing sold in the global market, 2018-2021 (Estimated)
Leading Newborn Genetic Testing Manufacturers –
Ariosa Diagnostics (Roche)
Berry Genomics
BGI
Bio-Rad Laboratories Inc.
Illumina
Laboratory Corporation of America
Natera
Qiagen
Sequenom
Trivitron Healthcare
Verinata Health
Agilent Technologies Inc.
Quest Diagnostics Incorporated
F. Hoffmann La-Roche Ltd.
PerkinElmer, Inc.
0 Comentรกrios
0 Compartilhamentos
1297 Visualizaรงรตes
0 Anterior